Intuitive Surgical (ISRG)

On 12 Nov 2026 Intuitive Surgical closed at $439.89, -22.3% this year; market cap $154.67bn, P/E 52.3.

About

Health Care · Health Care Equipment · NASDAQ · United States

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Key figures

Market cap$154.67bn
P/E (trailing)52.3
EPS (TTM)$8.41
Beta1.44
Dividend$0.00
Dividend yield0.00%
Ex-dividend date—
Latest report20 Oct 2026
Next earnings19 Jan 2027

Performance

YTD-22.3%
1Y-23.2%
3Y+15.9%
5Y+4.4%

Financials

YearRevenueNet incomeFree cash flow
2025$10.06bn$2.86bn$2.49bn
2024$8.35bn$2.32bn$1.30bn
2023$7.12bn$1.80bn$749.60m
2022$6.22bn$1.32bn$958.40m
2021$5.71bn$1.70bn$1.74bn

Valuation

Base value $404.89 (-8.0% vs price); 0 of 1 methods above the price. See every method

Options

Call and put prices: our price for each next to the market's.

Open in the dashboard · Run a full Desk Run

Data as of 12 Nov 2026. Not investment advice.